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SUMMARY 
A series of 3,6-substituted 2,5-bis(1-aziridinyl)-l,4-benzoquinone derivatives 
was shown to alkylate calf thymus DNA and to form DNA interstrand cross- 
links. Alkylation and cross-link formation were enhanced after electrochemi- 
cal reduction of the compounds and increased with lower pH in the pH range 
from 4.5 to 8.0. Reduction especially shifts the pH at which cross-linking and 
alkylation occurs to higher values, which are more physiologically relevant. 
This shift is probably caused by the increase in pK  value of the aziridine 
ring after reduction of the quinone moiety. The inactivation of single- 
stranded bacteriophage M13mp19 DNA to form phages in an E. coli host, by 
the 3,6-unsubstituted parent compound 2,5-bis(1-aziridinyl)~l,4-benzoquinone 
(TW13) was dependent upon reduction and pH in a similar way as was alky- 
lation. The compound in our series with the least bulky, 3,6-substitutents, 
TW13, caused a high amount of cross-link formation. Compounds with 
methyl-substituted aziridine rings showed low cross-linking ability. Our 
results support the concept hat the protonated reduced compound is the 
reactive species that alkylates DNA, and that steric factors play an impor- 
tant role in the reactivity towards DNA. A correlation is observed between 
the ability to induce DNA interstrand cross-links and inactivation of 
M13mp19 bacteriophage DNA. Cross-link formation was also demonstrated 
in E. coli K12 cells, where the compounds are reduced endogenously b bac- 
terial reductases. 
Abbreviations: AZQ, 2,5-bis(1-aziridinyl~3,5-bis(earboethoxyamino}-l,4-benzoquinone; BABQ, 2,5-
bis(1-aziridinyl)-l,4-benzoquinone; CbQ, Carboquone (2,5-bis(1-aziridinyl)-3-~2-(carbamoyloxy)-l- 
methoxyethyl]-6-methyl-l,4-benzoquinone) DMF, N,N-dimethylformamide. 
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INTRODUCTION 
Among the frequently used antitumour drugs in clinical use today, are 
many drugs containing a quinone moiety like mitomycin C, adriamycin and 
daunorubicin. It is generally assumed that these compounds are bioreduc- 
tively activated to alkylating species. They are therefore potentially useful 
drugs especially against solid tumours, because the cells of these tumours 
have a low oxygen tension as a consequence of poor vascularity [1]. 
Based on AZQ and related compounds evaluated by Driscoll et al. [2] we 
synthesized a series of 3,6-substituted 2,5-bis(1-aziridinyl)-l,4-benzoquinone 
(BABQ) derivatives (Fig. 1 and Table I). The quinone moiety can be reduced 
in two one electron steps via the semiquinone radical to the hydroquinone. 
After reduction, protonation of the aziridine ring is facilitated and an 
electrophilic species is formed. The slightly acidic pH of tumour cells addi- 
tionally might activate this protonation [3]. The electrophilic species is capa- 
ble of covalent binding to DNA as is shown for AZQ [4] and aziridine 
radiosensitizers [5]. 
The BABQ derivatives contain two aziridinyl groups enabling them to 
react bifunctionally to form DNA cross-links, as demonstrated for AZQ [4,6]. 
Generally DNA cross-links are more lethal than monoadducts [7]. 
In a previous paper [8] we reported the effects of these compounds on 
DNA, as studied with inactivation of M13mp19 single strand bacteriophage 
DNA and inhibition of colony forming ability of a DNA repair deficient E. 
coli K12 strain. In the present paper we report on a study of the alkylating 
properties of the BABQ derivatives. In particular the effect of pH and reduc- 
tive activation on DNA alkylation and cross-linking by BABQ derivatives 
o R2~ N---"~ 
Fig. 1. General structure of 2,5-bis(1-aziridinyl)-l,4-benzoquinones. 
TABLE I 
STRUCTURES OF 2,5-bis(1-AZIRIDINYL)-I,4-BENZOQUINONES 
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Compound R 1 R 2 R s 
AZq NHCOOEt NHCOOEt H 
TW 73 NHCOOEt NHCOOEt CH 3 
TW 53 CH s Br CH 8 
TW 87 CH 8 (CH2)2OCONH 2 CH 8 
CbQ CH s CH(OCHs)CH2OCONH z H 
TW 32 CH s C2H 6 H 
TW 25 Br C2H 5 H 
TW 39 CH 8 (CH~)2OCONH 2 H 
TW 13 H H H 
TW 26 Aziridinyl F H 
was investigated. Cross-link formation was determined with the ethidium 
bromide fluorescence assay [9,10]. We also investigated the cross-link forma- 
tion in intact E. coli cells, which activate BABQ derivatives by endogeneous 
bacterial reductases [8]. 
MATERIALS AND METHODS 
The BABQ derivatives were prepared or obtained as described previously 
[8]. TW23 (2-(1-aziridinyl~l,4-naphthoquinone) was prepared according to Ref. 
11. Stock solutions of the BABQ derivative contained 5 mM BABQ in DMF. 
Calf thymus DNA was from Sigma Chemical Company. 
RNAse A (EC 3.1.27.5) was from Boehringer Mannheim. Ingredients for 
bacterial media were obtained grom Difco Laboratories, Detroit, Michigan. 
All other chemicals were of analytical grade. Water was purified by Milli-Q 
filtration. E. coli K12-343/765 and 343/753 were obtained from Prof. Mohn, 
R.I.V.M., Bilthoven, The Netherlands. Glucose-phosphate buffer contained 2.8 
g glucose per 100 ml in 60 mM phosphate buffer (pH 7.1). The ethidium 
bromide measuring solution contained 0.5 ~g • m1-1 ethidium bromide and 0.4 
mM EDTA in 20 mM phosphate buffer (pH 12.0). 
Electrochemical reduction was performed after saturating the solution 
with nitrogen in a vessel kept at 25°C, using a radiometer K401 saturated 
calomel reference lectrode, a platinum wire auxiliary electrode, a 2-ml mer- 
cury pool cathode and a Brooker El00 potentiostat. UV/VIS spectra were 
recorded on a Perkin-Elmer Lambda-5 spectrophotometer. Fluorescence 
measurements were performed on a Perkin-Elmer LS-3 fluorescence spectro- 
meter. 
Alkylation of calf thymus DNA by TW13 
A solution containing 0.5 mM TW13 in 50 mM TRIS -- acetate buffer (pH 
7.0) containing 10% DMF from the TW13 stock solution, was electro- 
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chemically reduced in the dark at a potential that was 200 mV more negative 
than the half wave potential value of TWl3 ( -105 mV at pH 7 against Ag/ 
AgC1 [14]), until at least 900/0 of the compound was reduced as estimated 
from the limiting current. Usually this was achieved within 20 min. The ini- 
tial cathode current was 75/~A. From this solution 200 ~l was directly added 
to 200 ~1 of a solution containing 1.2 mg • m1-1 calf thymus DNA in 200 mM 
TRIS -- acetate buffer with a pH varying from 4.5 to 8.0. After incubation at 
37°C for 60 min, unbound TW13 was removed by spun~olumn chromatogra- 
phy over Sephadex G50 [12] and subsequent extractions with chloroform and 
diethylether. Sephadex G50 spun filtration removed 97% of TW13. Extrac- 
tions quantitatively removed the rest of TW13. The samples were diluted 
ten times and a UV/VIS spectrum was recorded. The amount of TW13 bound 
to DNA was expressed as the ratio between the UV maxima t 342 nm (max- 
imum absorption TW13 adduct) and 260 nm (maximum absorption DNA). 
To study the influence of the amount of reduction on alkylation, 100 ~l 
samples of the electrochemically reduced solution were taken at different 
time intervals and incubated with 100 ~1 of a solution containing 1.5 mg• ml "1 
calf thymus DNA at 37 °C for 60 min. 
The samples were then treated as described for the other samples. The 
amount of reduced TW13 at the time of sampling was estimated from the 
limiting current on the cathode. 
Inactivation of single stranded bacteriophage M13mp19 DNA 
M13mp19 DNA was incubated uring 60 rain at 37°C with 100 mM TRIS 
--acetate buffer of varying pH, in the presence of 1% TW13 stock solution 
(5 mM in DMF) or 1% DMF in control experiments. The pH values of  th~ 
incubation mixtures ranged from 4.1 to 7.0. M13mpl9 DNA was also reacted 
with electrochemically reduced TW13. A mixture containing 0.5 mM TW13, 
10% DMF and 50 mM potassium sulfate as electrolyte, was reduced electro- 
chemically as described above. After reduction, the mixture was diluted ten- 
fold in 110 mM TRIS-acetate  buffers in the pH range 4.5 to 8.0, containing 
M13mpl9 DNA, and incubated at 37°C for 60 min. Unbound TWl3 was 
removed by spun-column chromatography and ethanol precipitations of DNA. 
The viability of M13mp19 DNA was determined as described previously [8 ] .  
DNA interstrand cross-linking 
A solution, containing 0.05 mM BABQ derivative and 50 mM potassium 
sulphate in 10 mM TRIS -- acetate buffer (pH 7.0) (containing 1% DMF) was 
electrochemically reduced as described for TWl3. From this solution, 40 ~l 
was added to 360 ~l of a solution containing 0.67 mg• m1-1 calf thymus DNA 
in 30 mM TRIS -- acetate buffer in the pH range from 4.5 to 8.0. The mixture 
was incubated for 60 rain at 37°C. Unbound quinone was removed by spun- 
column chromatography over Sephadex GS0 and subsequent ethanol precipi- 
tations of DNA. The precipitated DNA was rehydrated in 100 /~l water 
overnight at 4 °C. In a cuvette 30 ~l of this DNA solution was mixed with 2 
ml ethidium bromide measuring solution and the fluorescence was measured. 
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For denaturation, the samples were put at 95°C during 3 min, allowed to 
cool at 20°C during 7 min and measured immediately. The ratio between the 
fluorescence after and before denaturation ((Fa/Fb)), compared to this ratio 
with a blank sample ({Fa/Fb)b), yielded a percentage cross-links with use of 
the formula [10] 
(Fa~Fb ) . -- ~J" a /Fb  ) b 
% cross-links -- × 100% 
1 -- ~Fa/Fb)  b 
N.B. It should be noted that the percentage cross-linking has no 
straightforward relation to the amount of base pairs that is cross-linked. The 
percentage cross-links in the formula is in fact the percentage return of dou- 
ble stranded DNA that causes fluorescence of ethidium bromide at pH 12.0. 
Cross-link formation in DNA isolated from intact E. coli cells 
E. coli K12~343/765 (wild type) was grown overnight in 10 ml nutrient 
broth [13], centrifuged, washed and resuspended in 7 ml glucose-phosphate 
buffer. The suspension contained approximately 109 cells/ml. After addition 
of 50 ~1 stock solution of TW13, the suspension was incubated at 37 °C under 
shaking. The viability of the cells was previously shown to remain constant 
under these circumstances [8]. 
Samples of 400 ~1 were diluted with 10 ml ice-cold TRIS-EDTA solution 
(0.02 M TRIS (pH 7.1) and 0.02 M EDTA) and centrifuged. Bacterial DNA 
was isolated following the procedure of Marmur [14]. RNA was removed by 
incubating the samples with 40 pg • m1-1. RNAse A in TRIS-EDTA buffer 
pH 8.0 (10 mM TRIS and 1 mM EDTA), for 60 min at 25°C. 
RESULTS AND DISCUSSION 
Alkylation of DNA by electrochemically reduced TWI3  results in the for- 
mation of adducts that absorb at 342 and 260 nm (Fig. 2). The absorp- 
tion max imum at 260 nm corresponds with the max imum absorption of DNA.  
The max imum at 342 nm does not correspond with that of TW13, which 
has max imum absorption at 324 nm. This change in absorption is not caused 
by reversible DNA binding (e.g. intercalation), as the association constant for 
reversible DNA binding of unreduced TW13, determined with equilibrium 
dialysis, appeared to be smaller than 100 M -I. However, the TW13 max imum 
shifts from 324 to 343 nm upon incubation in 50 mM acetate buffer of pH 4.0, 
possibly by formation of products with opened aziridine rings, as demon- 
strated with carboquone [15]. TW13 is one of the most active compounds to 
cause DNA modifications in our previous study on BABQ [8]. Attempts to 
assay the alkylating activity of less active compounds were not successful, as 
no or very low additional absorption at wavelengths longer than 300 nm 
could be observed after reaction with DNA.  
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Fig. 2. Absorption spectrum of TW13 alkylated DNA. Calf thymus DNA (1.2 mg • ml-~; 3.6 mM 
as nucleotides) was incubated in TRIS-acetate buffer (pH 6.0) at 37°C during 60 rain with 
electrochemically reduced TW13 (0.25 mM). Unbound TW13 was removed by gel filtration and 
extraction. 
Varying the extent of reduction of TW13, a linear relation is observed 
between the extent of reduction and the amount of DNA adducts (Fig. 3). 
Therefore, reduction is essential for covalent binding of TW13 to DNA at pH 
7.0. 
We studied the pH dependence of DNA alkylation by TW13 in a pH range 
of 4.5--8.0. When the pH decreases, the amount of adduct increases (Fig. 4). 
At low pH (pH ~ 4), TWl3 decomposes rapidly, so that alkylation does not 
increase any further, and eventually decreases. Furthermore, at pH ~ 4, pro- 
tonation of phosphate and amino groups of DNA occurs. This influences the 
reactivity of the electrophilic alkylating species. The observed reduction- 
dependent and pH-dependent alkylation is fully in accordance with the con- 
cept that BABQ acts as reductively activated species in protonated form. 
To study the consequences of DNA alkylation on the activity of DNA on a 
biological level, we studied the inactivation of bacteriophage M13mp19 DNA 
by TW13. As shown in Fig. 5, this inactivation was also dependent on both 
pH and reduction. TW13 induced inactivation of M13mp19 DNA increases 
with decreasing pH (curve b, Fig. 5). This effect is dramatically enhanced 
after reduction (curve c, Fig. 5). At low pH, M13mp19 DNA is damaged by 
pH effects (curve a, Fig. 5). The pH~lependence of inactivation of 
bacteriophage DNA can be fully explained by the increase of DNA alkylation 
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Fig. 3. Effect of extent of reduction on DNA alkylation by TW13. TW13 (0.25 mM) was electro- 
chemically reduced during different time intervals and incubated in 25 mM TRIS -- acetate 
buffer (pH 7.0) at 37 oC during 60 rain with calf thymus DNA (0.75) mg • ml-t; 2.2 mM as nucleo- 
tides). Unbound TW13 was removed by gel filtration and extraction. 
at lower pH. The effect of reduction of TW13 on bacteriophage inactivation 
is also in accordance with the alkylating ability. 
The cross-linking activity of our series of BABQ derivatives has been 
determined using the ethidium bromide fluorescence assay [9,10]. The results 
are shown in Fig. 6. TW23 (2~l-aziridinyD-1,4-napthoquinone) was used as a 
control, because it has only one aziridinyl group and therefore has no cross- 
linking potential. With TW23, no cross-linking activity at any pH was 
observed. The pH-proffles of cross-link formation are similar to that of 
DNA-alkylation by TW13 (Fig. 4). As in cross-linking two alkylation steps are 
involved, this result could indicate that the same mechanistic conditions con- 
trol both DNA cross-linking and DNA alkylation. 
The pH shift between the curves of reduced and unreduced rug are not 
the same for every compound (Fig. 6). This pH shift is expected to represent 
a difference in pK  value between the aziridine rings of the reduced and 
unreduced species. Driebergen [16] reported pK  values of our unreduced 
BABQ compounds ranging from 2.4 to 4.0 and from 7.8 to 9.7 for the reduced 
BABQ compounds. The pK a values of the unredueed compounds could not be 
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Fig. 4. pH-dependence of DNA aikylation by TW13. The reaction mixture contained calf thymus 
DNA (2 mM as nucleotides) and TW13 (0.25 mM) in 100 mM TRIS -- acetate buffer of varying pH. 
TW13 was electrochemically reduced (A) or used without reduction (O). 
determined accurately, since they are low, and at low pH degradation of the 
compounds is very rapid. The pK  values of the reduced compounds have 
been determined as pK,, d values, obtained from the pH dependence of elec- 
trochemical reductive cleavage of the aziridinyl ring, possible only after 
protonation [16]. These values appear to be 2--3 pH units higher than the 
pK  values that can be estimated from our cross-linking vs. pH curves. The 
pK,~ d values are indeed expected to be higher than the true pK  values of 
the aziridinyl rings of the hydroquinone, due to hydroquinone adsorption to 
the mercury electrode, and competition between reductive and hydrolytic 
ring opening [16]. Moreover, in the determination of the PK~d values it is not 
taken into account that the pK  value of the second aziridinyl ring could 
change, when the first aziridinyl ring has reacted with DNA. 
When these drugs are to be used as bioreductively activated drugs 
against solid tumours, they must be unreactive at pH 7 in oxidized form, but 
active in the reduced form, preferably at intracellular pH, which for tumour 
cells is probably slightly acidic [3]. A high cross-linking potential and a large 
pK  shift after reduction are expected to be useful properties for drug selec- 
tivity against solid tumours. Carboquone, TW39 and to a lesser extent TW32 
cause a high level of cross-link formation after reduction and are inactive at 
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Fig. 5. Inactivation of single-stranded bacteriophage M13mpl9, as assayed by transfection in E. 
coli JM 105. N O and N are the number of plaques at t = 0 and after exposure to TW13, respec- 
tively. [] (curve a) incubation of M13mp19 DNA in TRIS -- acetate buffers of varying pH during 
1 h at 37°C; • (curve b), incubation in TR IS -acetate  buffers of varying pH in the presence of 
50/~I  TW13; O (curve c), incubation of TRIS -- acetate buffers of varying pH in the presence of 
50 mM electrochemicaly reduced TW13. 
physiological pH in the oxidized form. The oxidized form of TW13, however, 
forms cross-links already at pH 7.0, therefore TW13 is not expected to be a 
specifically useful drug. 
Comparing the cross-linking activity with the previously determined DNA 
inactivation (Table II), we see that BABQ compounds containing a 2-methyl- 
aziridinyl group, which were the least active in the DNA inactivation tests, 
also produce the smallest amount of cross-links. A correlation between the 
amount of cross-links and inactivation of M13mp19 DNA or E. coli K12 can 
be observed (Fig. 7). The best correlation was between the inactivation of 
bacteriophage M13mp19 DNA (at pH 7.0) and the amount of cross-links at pH 
5.0. Diaziquone (AZQ) produces relatively more cross-links than expected 
from its low activity in the DNA inactivation tests. King et al. [4] observed a
comparable pH-dependence of cross-linking of calf thymus DNA with AZQ. 
Of the studied BABQ derivatives, TW13, a very active compound in our 
previous DNA inactivation tests (Table II), produced a high amount of cross- 
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Fig. 6. pH~lependence of DNA-DNA interstrand cross-link formation in calf thymus DNA (0.60 
mg • ml-1; 1.8 mM as nucleotides) in 30 mM TRIS  - acetate buffer of varying pH, by various 2,6 
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reduction (n). DMF is a control experiment without BABQ compound. TW23 is a control experi- 
ment with a monofunctional aziridine compound, which cannot form DNA cross-links. 
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TABLE II 
ACTIVITIES OF 2,5-bis(1-AZIRIDINYL)-I,4-BENZOQUINONES 
Compound Activity in E. coli k12 Activity in M13 Percentage cross-linking 
DNA repair test" DNA inactivation test" at pH = 5 with reduction 
AZQ 0.03 0.03 14 
TW 73 0.03 0.04 2 
TW 53 0.04 0.06 3 
TW 87 0.07 0.13 13 
CbQ 0.22 0.22 26 
TW 32 0.49 0.43 23 
TW 25 0.51 0.35 15 
TW 39 1.00 1.00 27 
TW 13 2.36 1.32 29 
TW 26 3.76 1.29 17 
• Ref. 8. 
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Fig. 7. Correlation between inactivation of bacteriophage M13mp19 DNA inactivation at pH 7.0 
and the amount of cross-links at pH 5.0 by the various BABQ compounds. In = 10; correlation 
coefficient = 0.78). 
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Fig. 8. Time-dependence of DNA interstrand cross-link formation i E. coli K12~343/765 by
TWl3. A suspension f E. coli K12-343/765 ( ± 10 ° cells • m1-1) in glucose-phosphate buffer (pH 
7.1) was incubated with TW13 at 37°C under shaking. Samples were taken at different time 
intervals. DNA was isolated, and assayed for cross-links with the ethidium bromide fluorescence 
assay. 
links at neutral pH (6--7). Generally, the presence of more bulky R 1 and R 2 
substituents decreases the amount of cross-links. The three compounds with 
methylated aziridine rings (R 8 -- CH 3) produced very low amounts of cross- 
links. These results confirm our previous finding that steric factors are 
important in the alkylation reaction [8]. 
To study cross-link formation on a cellular level, we used E. coli K12, in 
which TW13 is activated endogenously by bacterial reductases [8]. In Fig. 8 
the formation of cross-links in E. coli K12-343/765 is shown. The amount of 
cross-links reaches a constant value after 20 min. This plateau may be due to 
an equilibrium between cross-link formation and repair of cross-links. The 
viability of these DNA repair proficient cells remained unchanged by the 
TW13 treatment, while DNA repair deficient E. coli K12-343/753 (UVR-B-, 
recA-) were inactivated under these circumstances [8]. The alkylating elec- 
trophilic form of these aziridinyl compounds probably resembles that of the 
alkylating nitrogen mustards, the aziridinium cation [17]. Therefore, we 
expect that analogously to the mustard compounds the N7 of guanine is an 
especially likely candidate for alkylation [18]. The chemical nature of the 
DNA adducts evidently has to be established. To study this, experiments are 
in progress in our laboratory. 
In summary, we demonstrated that 2,5-bis(1-aziridinyl)~l,4-benzoqu in nes 
are capable of alkylating DNA and forming DNA interstrand cross-links. 
Alkylation and cross-link formation are dependent on reduction and pH in 
such a way, that it can be concluded that reduction and protonation of the 
aziridine ring are mechanistic prerequisites for DNA alkylation. The biologi- 
cal consequences of DNA alkylation by BABQ derivatives may appear from 
the inactivation of bacteriophage DNA, which is apparently coherent with 
the extent of DNA alkylation. Furthermore, steric effects are important: 
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BABQ derivatives with methylated aziridine rings and bulky 3,6-substituents 
have lower cross-link formation abilities. 
pK a shifts between the oxidized and reduced compound are different for 
the various BABQ derivatives. This offers perspectives for development of 
compounds with more selectivity for tumour cells. 
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